SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Diagnocure CUR
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cal Gary who wrote (128)11/27/2001 6:02:55 PM
From: Mr. L. Neufeldt  Read Replies (1) of 132
 
The CEO and Pres., Mr. Desy has been buying shares personally Oct. 23 and Nov. 9th.
Each of these has been days prior to a news release.
No other major shareholder has bought or sold since the fall off in May 2000. They've all ridden this one down to where it's at currently.
I'm led to believe Desy's been in Europe and the US the last several weeks. I presume he must be showing preliminary results from the uPM3 preliminary clinical trial even though nothing has been officially released.
I'm sure he would prefer to do a deal with a pharmaceutical company in lieu of a prospectus.
I'm led to believe the hospitals have not given the information back to the CRO in a timely manner and this is the reason for a delay in results.
The $1 billion question is, "Are the results good enough to push this stock and how far?"
The increase in volume is still surrounded by uncertainty in the final results.
You can gamble and buy a small amount or just sit tight and wait for the uPM3 news and ride the wave. (If there is one)

Actually, I shouldn't sound so negative. The early tests done indicate uPM3 has huge potential. Our cash is running out in the company and that has put us seriously in jeopardy of running out of money. The pressure is on Desy to do a pharmaceutical deal or a prospectus or both.
I'm trusting that his buying of shares in the company means the news is going to be positive. If the news is positive he should be able to get a pharmaceutical deal and thereby avoid share dilution through a prospectus.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News